Market Introduction
The allergies are hypersensitive responses from human immune system to the substance that come in contact with body. Severe allergy can be life threatening which disturb the normal functioning of organs such as asthma causes poor functioning of lungs. The most effective treatment for allergy is to avoid the known allergens, while there are medications such as steroids and antihistamines and other therapies which prevent allergies.
Market Overview and Dynamics
The Europe allergy treatment market is expected to reach US$ 10,424.97 million by 2028 from US$ 6,036.60 million in 2020, it is estimated to grow at a CAGR of 7.1% from 2021 to 2028. The market growth is attributed to key driving factors such as increase in adoption of immunotherapy in allergy treatment and developments in food allergy treatments. However, the lack of awareness about allergy treatments restrains the market growth.
Key Market Segments
The Europe allergy treatment market, based on allergy type, is segmented into eye allergy, rhinitis, asthma, skin allergy, food allergies, and other allergies. In 2020, the rhinitis segment held the largest share of the market, whereas the market for the food allergies segment is expected to grow at the fastest rate during the coming years.
The Europe allergy treatment market, based on treatment, is bifurcated into anti-allergy drugs and immunotherapy. In 2020, the anti-allergy drugs segment held a larger market share. However, the market for the immunotherapy segment is expected to grow at the fastest rate during the coming years.
Major Sources and Companies Listed
A few of the primary and secondary sources associated with this report on the Europe allergy treatment market are Allergy UK Organization (AUKO), European Academy of Allergy and Clinical Immunology (EAACI) and Spanish Society of Pneumology and Thoracic Surgery (SEPAR).
Reasons to buy the report
EUROPE ALLERGY TREATMENT MARKET SEGMENTATION
By Allergy Type:
By Treatment:
By Country
Company Profiles
| Report Attribute | Details |
|---|---|
| Market size in 2020 | US$ 6,036.60 Million |
| Market Size by 2028 | US$ 10,424.97 Million |
| CAGR (2021 - 2028) | 7.1% |
| Historical Data | 2018-2019 |
| Forecast period | 2021-2028 |
| Segments Covered |
By Allergy Type
|
|
Regions and Countries Covered
|
|
| Europe | UK, Germany, France, Russia, Italy, Rest of Europe |
| Market leaders and key company profiles |
|
The Europe Allergy Treatment Market is valued at US$ 6,036.60 Million in 2020, it is projected to reach US$ 10,424.97 Million by 2028.
As per our report Europe Allergy Treatment Market, the market size is valued at US$ 6,036.60 Million in 2020, projecting it to reach US$ 10,424.97 Million by 2028. This translates to a CAGR of approximately 7.1% during the forecast period.
The Europe Allergy Treatment Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Allergy Treatment Market report:
The Europe Allergy Treatment Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Allergy Treatment Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Allergy Treatment Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)